Barriers to the utilization of thrombolysis for acute ischaemic stroke

被引:51
作者
Eissa, A. [1 ]
Krass, I. [1 ]
Bajorek, B. V. [2 ,3 ]
机构
[1] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[2] Royal N Shore Hosp, St Leonards, NSW 2065, Australia
[3] Univ Technol Sydney, Sch Pharm, Broadway, NSW, Australia
关键词
alteplase; barriers; cerebrovascular accident; stroke; thrombolysis; tissue plasminogen activator; TISSUE-PLASMINOGEN ACTIVATOR; RISK-FACTORS; WARNING SIGNS; BRAIN ATTACK; SCIENTIFIC STATEMENT; CASE-FATALITY; MR MISMATCH; EMERGENCY; CARE; ALTEPLASE;
D O I
10.1111/j.1365-2710.2011.01329.x
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
What is known and Objective: Thrombolysis is currently the only evidence-based pharmacological treatment available for acute ischaemic stroke (AIS); however, its current utilization is suboptimal (administered to <3% of AIS patients). The aim of this article was to identify the potential barriers to the use of thrombolysis via a review of the available literature. Methods: Medline, Embase, International Pharmaceutical Abstracts and Google Scholar were searched to identify relevant original articles, review papers and other literature published in the period 19952011. Results and Discussion: Several barriers to the utilization of thrombolysis in stroke have been identified in the literature and can be broadly classified as preadmission barriers and post-admission barriers. Preadmission barriers include patient and paramedic-related factors leading to late patient presentation for treatment (i.e. outside the therapeutic time window for the administration of thrombolysis). Post-admission barriers include in-hospital factors, such as suboptimal triage of stroke patients and inefficient in-hospital acute stroke care systems, a lack of appropriate infrastructure and expertise to administer thrombolysis, physician uncertainty in prescribing thrombolysis and difficulty in obtaining informed consent for thrombolysis. Suggested strategies to overcome these barriers include public awareness campaigns, prehospital triage by paramedics, hospital bypass protocols and prenotification systems, urgent stroke-unit admission, on-call multidisciplinary acute stroke teams, urgent neuroimaging protocols, telestroke interventions and risk-assessment tools to aid physicians when considering thrombolysis. Additionally, greater pharmacists engagement is warranted to help identify the people at risk of stroke and support preventative strategies, and provide the public with information regarding the recognition of stroke, as well as facilitate the access and use of thrombolysis. What is new and Conclusion: The most effective interventions appear to be those comprising several strategies and those that target more than one barrier simultaneously. Therefore, optimal utilization of thrombolysis requires a systematic, integrated multidisciplinary approach across the continuum of acute care.
引用
收藏
页码:399 / 409
页数:11
相关论文
共 96 条
[1]
Guidelines for the early management of adults with ischemic stroke - A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups [J].
Adams, Harold P., Jr. ;
del Zoppo, Gregory ;
Alberts, Mark J. ;
Bhatt, Deepak L. ;
Brass, Lawrence ;
Furlan, Anthony ;
Grubb, Robert L. ;
Higashida, Randall T. ;
Jauch, Edward C. ;
Kidwell, Chelsea ;
Lyden, Patrick D. ;
Morgenstern, Lewis B. ;
Qureshi, Adnan I. ;
Rosenwasser, Robert H. ;
Scott, Phillip A. ;
Wijdicks, Eelco F. M. .
STROKE, 2007, 38 (05) :1655-1711
[2]
Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke? [J].
Akins, PT ;
Delemos, C ;
Wentworth, D ;
Byer, J ;
Schorer, SJ ;
Atkinson, RP .
NEUROLOGY, 2000, 55 (12) :1801-1805
[3]
Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study [J].
Albers, GW ;
Bates, VE ;
Clark, WM ;
Bell, R ;
Verro, P ;
Hamilton, SA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1145-1150
[4]
Recommendations for the establishment of primary stroke centers [J].
Alberts, MJ ;
Hademenos, G ;
Latchaw, RE ;
Jagoda, A ;
Marler, JR ;
Mayberg, MR ;
Starke, RD ;
Todd, HW ;
Viste, KM ;
Girgus, M ;
Shephard, T ;
Emr, M ;
Shwayder, P ;
Walker, MD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (23) :3102-3109
[5]
[Anonymous], NAT STROK AUD AC SER
[6]
[Anonymous], 2010, CLIN GUID STROK MAN
[7]
[Anonymous], 2009, National stroke audit acute services clinical audit report 2009
[8]
Asplund K, 1997, BMJ-BRIT MED J, V314, P1151
[9]
Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: A pharmacist-led multidisciplinary intervention [J].
Bajorek, BV ;
Krass, I ;
Ogle, SJ ;
Duguid, MJ ;
Shenfield, GM .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (11) :1912-1920
[10]
Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility [J].
Barber, PA ;
Zhang, J ;
Demchuk, AM ;
Hill, MD ;
Buchan, AM .
NEUROLOGY, 2001, 56 (08) :1015-1020